Trial leadership index

Map & ranking Research output

Publication counts reward volume. This index rewards presence in the evidence that changed practice: the trials, products, and technologies recorded in OnCo that an institution or cooperative group is linked to. It is disclosed, simple, and only as complete as the corpus.

score = 3 × linked trials + 2 × linked products + linked technologies + linked targets, counting distinct OnCo objects connected in either direction. Cooperative groups (SWOG, NRG, Alliance, BIG…) are included because they, not single hospitals, run most academic phase 3 trials. To move an institution up, document the trial it led and link it.

#	Institution	Trials	Products	Technologies	Targets	Score
1	GOG Foundation Philadelphia, PA, US	6 · GOG-0218 & ICON7, KEYNOTE-A18 / ENGOT-cx11 / GOG-3047, MIRASOL / GOG-3045 +3 more	3 · Dostarlimab, Mirvetuximab soravtansine, Pembrolizumab	3	0	27
2	Cancer Research UK London, GB	8 · ABC-02, Add-Aspirin, BILCAP +5 more	—	1	0	25
3	Children's Oncology Group (COG) Monrovia, CA, US	7 · AHOD2131, COG AALL1731, COG ANBL0032 +4 more	1 · Blinatumomab	1	0	24
4	Society of Gynecologic Oncology Chicago, IL, US	5 · KEYNOTE-A18 / ENGOT-cx11 / GOG-3047, LACC, NRG-GY018 / KEYNOTE-868 +2 more	—	5	0	20
5	Guangdong Provincial People's Hospital Guangzhou, CN	2 · ADAURA, FLAURA2	3 · Erlotinib, Gefitinib, Osimertinib	3	3	18
6	West German Cancer Center (WTZ), University Hospital Essen Essen, DE	2 · CheckMate 067, VISION	4 · Ipilimumab, Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan +1 more	4	0	18
7	NRG Oncology Philadelphia, PA, US	4 · NRG-GY018 / KEYNOTE-868, NRG-HN002 & NRG-HN005, OlympiA +1 more	2 · ArteraAI Prostate, Olaparib	0	0	16
8	Breast Cancer Trials Newcastle, NSW, AU	3 · APHINITY, OlympiA, SOFT & TEXT	2 · Olaparib, Trastuzumab	2	0	15
9	NSABP Foundation Pittsburgh, PA, US	2 · HERA, NSABP B-31 & NCCTG N9831, KATHERINE	3 · Oncotype DX, Trastuzumab, Trastuzumab emtansine	3	0	15
10	Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Naples, IT	1 · CheckMate 067	3 · Ipilimumab, Nivolumab, Relatlimab + nivolumab	3	3	15
11	Alliance for Clinical Trials in Oncology Chicago, IL, US	3 · ATOMIC, CABINET, OptimICE-pCR	2 · Carboplatin, Pembrolizumab	1	0	14
12	Guy's and St Thomas' NHS Foundation Trust / King's Health Partners Cancer Centre London, GB	2 · NHS-Galleri, OlympiA	2 · Galleri, Olaparib	4	0	14
13	LYSA – The Lymphoma Study Association Pierre-Bénite (Lyon), FR	2 · POLARIX, PRIMA / ENGOT-OV26	2 · Axicabtagene ciloleucel, Glofitamab	4	0	14
14	Shanghai Chest Hospital Shanghai, CN	—	4 · Amivantamab, Ivonescimab, Lorlatinib +1 more	2	4	14
15	Dana-Farber Brigham Cancer Center Boston, US	3 · BWEL, KEYNOTE-522, RASolute 302	—	4	0	13
16	ARCAGY-GINECO Paris, FR	2 · GOG-0218 & ICON7, PAOLA-1 / ENGOT-ov25	2 · Niraparib, Olaparib	3	0	13
17	Georgetown Lombardi Comprehensive Cancer Center Washington, DC, US	1 · CLEOPATRA	3 · Docetaxel, Pertuzumab, Trastuzumab	2	2	13
18	Memorial Sloan Kettering Cancer Center New York, US	1 · AZUR-1	1 · Dostarlimab	8	0	13
19	National Cancer Center Hospital East Kashiwa, Chiba, JP	—	2 · Nivolumab, Trastuzumab deruxtecan	5	4	13
20	Society of Nuclear Medicine and Molecular Imaging Reston, VA, US	—	3 · Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan, Piflufolastat F-18 / Pylarify TruVu	7	0	13
21	National Taiwan University Hospital Taipei, TW	—	3 · Afatinib, Atezolizumab, Osimertinib	3	3	12
22	University of Colorado Cancer Center Aurora, CO, US	—	4 · Crizotinib, Entrectinib, Larotrectinib +1 more	1	3	12
23	Netherlands Cancer Institute (NKI-AvL) Amsterdam, NL	3 · NADINA, NICHE-2, OVHIPEC-1	—	2	0	11
24	SWOG Cancer Research Network Portland, OR, US	3 · SCARLET, SWOG S1801, SWOG S1826	1 · Nivolumab	0	0	11
25	ANZUP Cancer Trials Group Sydney, AU	2 · proPSMA, TheraP	1 · Lutetium-177 vipivotide tetraxetan	3	0	11
26	ECOG-ACRIN Cancer Research Group Philadelphia, PA, US	2 · DREAMseq, ECOG-ACRIN E1910	2 · Blinatumomab, Capecitabine + temozolomide	1	0	11
27	National Cancer Center Hospital Tokyo, JP	2 · CIRCULATE-Japan, ROMANA 1 and ROMANA 2	2 · Datopotamab deruxtecan, Trastuzumab deruxtecan	1	0	11
28	Winship Cancer Institute of Emory University Atlanta, GA, US	1 · RxPONDER	3 · Daratumumab, Oncotype DX, Osimertinib	0	2	11
29	Children's Hospital of Philadelphia Philadelphia, PA, US	—	3 · Crizotinib, Lorlatinib, Tisagenlecleucel	3	2	11
30	ETOP IBCSG Partners Foundation Bern, CH	2 · BEAT-meso, SOFT & TEXT	1 · Atezolizumab	2	0	10
31	Gustave Roussy Villejuif, FR	2 · ESTIMABL2, PEACE-1	2 · Datopotamab deruxtecan, Trastuzumab deruxtecan	0	0	10
32	MD Anderson Cancer Center Houston, US	2 · LACC, ROAR	—	4	0	10
33	Peter MacCallum Cancer Centre Melbourne, AU	2 · proPSMA, TheraP	1 · Lutetium-177 vipivotide tetraxetan	2	0	10
34	German Hodgkin Study Group Cologne, DE	1 · GHSG HD21	2 · Brentuximab vedotin, Nivolumab	3	0	10
35	GIMEMA Rome, IT	1 · D-ALBA	2 · Blinatumomab, Imatinib	3	0	10
36	The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute Columbus, OH, US	1 · RESONATE	2 · Acalabrutinib, Ibrutinib	1	2	10
37	Comprehensive Cancer Center Mainfranken, University Hospital Würzburg Würzburg, DE	—	2 · Ciltacabtagene autoleucel, Teclistamab	4	2	10
38	Hospital Universitario 12 de Octubre Madrid, ES	—	2 · Durvalumab, Tarlatamab	4	2	10
39	Inselspital, Bern University Hospital / University Cancer Center Inselspital Bern, CH	—	2 · Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan	4	2	10
40	Istituto di Candiolo IRCCS – FPO Candiolo, IT	—	1 · Trastuzumab	4	4	10
41	Peking University Cancer Hospital Beijing, CN	—	2 · Disitamab vedotin, Satricabtagene autoleucel	3	3	10
42	Stanford Health Care / Stanford Cancer Institute Stanford, US	—	—	9	1	10
43	SIOP Europe – European Society for Paediatric Oncology Brussels, BE	3 · Euro Ewing 2012, Interfant-06, SIOPEN HR-NBL1	—	0	0	9
44	National Cancer Institute (NIH) Bethesda, MD, US	1 · myeloMATCH	—	6	0	9
45	The Institute of Cancer Research London, GB	1 · STAMPEDE	3 · Abiraterone acetate, Capivasertib, Olaparib	0	0	9
46	The Royal Marsden London, GB	1 · STAMPEDE	2 · Abiraterone acetate, Olaparib	2	0	9
47	European Association of Nuclear Medicine Vienna, AT	—	2 · Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan	5	0	9
48	IRCCS Azienda Ospedaliero-Universitaria di Bologna – Policlinico Sant'Orsola Bologna, IT	—	2 · Glofitamab, Teclistamab	3	2	9
49	IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori' (IRST) Meldola, IT	—	2 · Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan	3	2	9
50	NCI Center for Cancer Research (intramural programme) Bethesda, MD, US	—	1 · Aldesleukin	5	2	9
51	UCLA Jonsson Comprehensive Cancer Center Los Angeles, US	—	3 · Gallium-68 gozetotide, Palbociclib, Trastuzumab	1	2	9
52	University Hospital Düsseldorf / CIO Düsseldorf Düsseldorf, DE	—	2 · FAP-2286, Lutetium-177 vipivotide tetraxetan	3	2	9
53	University Hospital Zurich / Comprehensive Cancer Center Zurich Zurich, CH	—	2 · Optune / Optune Pax, Talimogene laherparepvec	5	0	9
54	Tata Memorial Centre Mumbai, IN	2 · Add-Aspirin, Low-dose olanzapine for cancer anorexia	—	2	0	8
55	Vall d'Hebron University Hospital / VHIO Barcelona, ES	2 · DESTINY-Breast03, DESTINY-Breast09	1 · Encorafenib	0	0	8
56	Chulabhorn Hospital / Chulabhorn Royal Academy Bangkok, TH	—	2 · Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan	4	0	8
57	Dartmouth Cancer Center Lebanon, NH, US	—	2 · Ipilimumab, Nivolumab	2	2	8
58	Erasmus MC Cancer Institute Rotterdam, NL	—	1 · Lutetium-177 dotatate	5	1	8
59	Institut Jules Bordet Brussels, BE	—	2 · Pembrolizumab, Trastuzumab	4	0	8
60	IRCCS Humanitas Research Hospital Rozzano (Milan), IT	—	2 · Atezolizumab, Durvalumab	4	0	8
61	IUCT Oncopole – Institut Universitaire du Cancer de Toulouse Toulouse, FR	—	2 · Ciltacabtagene autoleucel, Teclistamab	4	0	8
62	Oxford Cancer – Oxford University Hospitals and University of Oxford Oxford, GB	—	1 · Tebentafusp	5	1	8
63	Postgraduate Institute of Medical Education and Research, Chandigarh Chandigarh, IN	—	2 · Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan	4	0	8
64	Sheba Medical Center Ramat Gan, IL	—	1 · Olaparib	4	2	8
65	SOLTI Cancer Research Group Barcelona, ES	—	3 · Palbociclib, Ribociclib, Trastuzumab	2	0	8
66	Stephenson Cancer Center, OU Health Oklahoma City, OK, US	—	2 · Mirvetuximab soravtansine, Olaparib	2	2	8
67	TUM Klinikum rechts der Isar / CCC München Munich, DE	—	2 · Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan	4	0	8
68	UC San Diego Moores Cancer Center La Jolla, CA, US	—	2 · Dinutuximab (ch14.18) / dinutuximab beta, Zilovertamab vedotin	2	2	8
69	UPMC Hillman Cancer Center Pittsburgh, PA, US	—	3 · Cetuximab, Relatlimab + nivolumab, Tamoxifen	1	1	8
70	Austrian Breast & Colorectal Cancer Study Group Vienna, AT	1 · PALLAS & PENELOPE-B	1 · Palbociclib	2	0	7
71	Breast International Group (BIG) Brussels, BE	1 · OlympiA	2 · Olaparib, Trastuzumab	0	0	7
72	German Breast Group (GBG) Neu-Isenburg, DE	1 · GHSG HD21	2 · Carboplatin, Durvalumab	0	0	7
73	Society of Surgical Oncology Rosemont, IL, US	1 · MSLT-II	—	4	0	7
74	Abramson Cancer Center, University of Pennsylvania Philadelphia, US	—	—	5	2	7
75	Advanced Centre for Treatment, Research and Education in Cancer Navi Mumbai, IN	—	1 · Nivolumab	4	1	7
76	Centre hospitalier de l'Université de Montréal (CHUM) Montréal, QC, CA	—	2 · Abiraterone acetate, Olaparib	3	0	7
77	Comprehensive Cancer Center Vienna – Medical University of Vienna / AKH Vienna, AT	—	1 · Palbociclib	5	0	7
78	Hadassah Medical Center Jerusalem, IL	—	—	4	3	7
79	Huntsman Cancer Institute, University of Utah Salt Lake City, UT, US	—	2 · Enzalutamide, Talazoparib	2	1	7
80	Instituto Alexander Fleming Buenos Aires, AR	—	2 · Palbociclib, Trastuzumab	1	2	7
81	IRCCS Ospedale San Raffaele Milan, IT	—	1 · Trastuzumab	4	1	7
82	Kyoto University Hospital Kyoto, JP	—	1 · Nivolumab	3	2	7
83	National Cancer Centre Singapore Singapore, SG	—	—	4	3	7
84	National Medical Products Administration / Center for Drug Evaluation Beijing, CN	—	2 · Disitamab vedotin, Ivonescimab	3	0	7
85	Purdue Institute for Cancer Research West Lafayette, IN, US	—	1 · Lutetium-177 vipivotide tetraxetan	3	2	7
86	Ruijin Hospital, Shanghai Jiao Tong University Shanghai, CN	—	2 · Arsenic trioxide, Tretinoin	3	0	7
87	Seoul St. Mary's Hospital Seoul, KR	—	2 · Imatinib, Nilotinib	3	0	7
88	Shanghai Pulmonary Hospital Shanghai, CN	—	—	4	3	7
89	Uppsala University Hospital / Uppsala University Uppsala, SE	—	1 · Lutetium-177 dotatate	4	1	7
90	Weizmann Institute of Science Rehovot, IL	—	—	4	3	7
91	Australasian Gastro-Intestinal Trials Group Sydney, AU	1 · DYNAMIC	—	3	0	6
92	HOVON Rotterdam, NL	1 · PERSEUS	1 · Venetoclax	1	0	6
93	Montefiore Einstein Comprehensive Cancer Center Bronx, NY, US	1 · TAILORx	1 · Oncotype DX	1	0	6
94	TROG Cancer Research Newcastle, NSW, AU	1 · PORTEC-3	—	3	0	6
95	All India Institute of Medical Sciences, New Delhi New Delhi, IN	—	—	6	0	6
96	American Society for Radiation Oncology Arlington, VA, US	—	—	6	0	6
97	BC Cancer Vancouver, BC, CA	—	1 · Brentuximab vedotin	4	0	6
98	Beatson West of Scotland Cancer Centre / CRUK Scotland Institute Glasgow, GB	—	—	4	2	6
99	Central Drugs Standard Control Organization New Delhi, IN	—	2 · Imatinib, Trastuzumab	2	0	6
100	Centro Nacional de Investigaciones Oncológicas (CNIO) Madrid, ES	—	—	4	2	6
101	Comprehensive Cancer Center Tübingen-Stuttgart Tübingen, DE	—	1 · Afamitresgene autoleucel	4	0	6
102	European Society for Radiotherapy and Oncology Brussels, BE	—	—	6	0	6
103	Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Dallas, TX, US	—	1 · Belzutifan	3	1	6
104	Heidelberg University Hospital / NCT / DKFZ Heidelberg, DE	—	—	4	2	6
105	Hospital Clínic de Barcelona / IDIBAPS Barcelona, ES	—	—	4	2	6
106	Hospital del Mar / Hospital del Mar Research Institute Barcelona, ES	—	1 · Trastuzumab	3	1	6
107	Institute of Oncology Ljubljana Ljubljana, SI	—	1 · Carboplatin	4	0	6
108	Laura and Isaac Perlmutter Cancer Center at NYU Langone Health New York, NY, US	—	1 · Nivolumab	2	2	6
109	Lausanne University Hospital (CHUV) / Ludwig Institute Lausanne Lausanne, CH	—	1 · Pembrolizumab	4	0	6
110	Mayo Clinic Comprehensive Cancer Center – Florida Jacksonville, FL, US	—	—	4	2	6
111	OHSU Knight Cancer Institute Portland, OR, US	—	1 · Imatinib	3	1	6
112	Pharmaceuticals and Medical Devices Agency Tokyo, JP	—	2 · Osimertinib, Trastuzumab deruxtecan	2	0	6
113	Robert H. Lurie Comprehensive Cancer Center of Northwestern University Chicago, IL, US	—	2 · Optune / Optune Pax, Temozolomide	2	0	6
114	Society for Immunotherapy of Cancer Milwaukee, WI, US	—	—	6	0	6
115	University of Wisconsin Carbone Cancer Center Madison, WI, US	—	1 · Dinutuximab (ch14.18) / dinutuximab beta	3	1	6
116	UZ Leuven / Leuven Cancer Institute Leuven, BE	—	—	4	2	6
117	Walter and Eliza Hall Institute of Medical Research Melbourne, AU	—	1 · Venetoclax	3	1	6
118	Wellcome Sanger Institute Hinxton, GB	—	—	5	1	6
119	Zhongshan Hospital, Fudan University Shanghai, CN	—	—	3	3	6
120	Sun Yat-sen University Cancer Center Guangzhou, CN	1 · JUPITER-02	1 · Izalontamab brengitecan	0	0	5
121	Cancer Center Clínica Universidad de Navarra / CIMA Pamplona, ES	—	—	5	0	5
122	Cancer Research UK Cambridge Centre / CRUK Cambridge Institute Cambridge, GB	—	—	5	0	5
123	Chinese PLA General Hospital Beijing, CN	—	—	4	1	5
124	Chinese Society of Clinical Oncology Beijing, CN	—	1 · Ivonescimab	3	0	5
125	Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine Houston, TX, US	—	—	4	1	5
126	David H. Koch Institute for Integrative Cancer Research at MIT Cambridge, MA, US	—	—	3	2	5
127	GEICAM Spanish Breast Cancer Group Madrid, ES	—	1 · Palbociclib	3	0	5
128	Holden Comprehensive Cancer Center, University of Iowa Iowa City, IA, US	—	1 · Lutetium-177 dotatate	2	1	5
129	Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, IN, US	—	1 · Cisplatin	3	0	5
130	Instituto Nacional de Cancerología (Mexico) Mexico City, MX	—	—	5	0	5
131	Instituto Português de Oncologia do Porto Francisco Gentil Porto, PT	—	—	4	1	5
132	International Agency for Research on Cancer (IARC / WHO) Lyon, FR	—	—	5	0	5
133	International Association for the Study of Lung Cancer Denver, CO, US	—	—	5	0	5
134	IRCCS Regina Elena National Cancer Institute Rome, IT	—	—	4	1	5
135	Istituto Oncologico Veneto IRCCS Padua, IT	—	1 · Trastuzumab	3	0	5
136	Kenyatta National Hospital Nairobi, KE	—	—	5	0	5
137	King Faisal Specialist Hospital and Research Centre Riyadh, SA	—	—	5	0	5
138	King Hussein Cancer Center Amman, JO	—	—	5	0	5
139	Lagos University Teaching Hospital Lagos, NG	—	—	4	1	5
140	Masaryk Memorial Cancer Institute Brno, CZ	—	—	4	1	5
141	Massachusetts General Hospital Cancer Center Boston, US	—	—	5	0	5
142	NCT/UCC Dresden – University Hospital Carl Gustav Carus Dresden, DE	—	—	5	0	5
143	Newcastle Cancer Centre / Northern Centre for Cancer Care Newcastle upon Tyne, GB	—	—	3	2	5
144	Oslo University Hospital – The Norwegian Radium Hospital Oslo, NO	—	—	5	0	5
145	Princess Máxima Center for Pediatric Oncology Utrecht, NL	—	—	5	0	5
146	Shandong Cancer Hospital and Institute Jinan, CN	—	—	5	0	5
147	Sunnybrook Odette Cancer Centre Toronto, ON, CA	—	—	5	0	5
148	Sydney Children's Hospitals Network / Children's Cancer Institute Sydney, AU	—	—	5	0	5
149	UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, US	—	1 · Gallium-68 gozetotide	1	2	5
150	UMC Utrecht Cancer Center Utrecht, NL	—	—	5	0	5
151	Union Hospital, Tongji Medical College Wuhan, CN	—	—	3	2	5
152	University Cancer Center Mainz (UCT Mainz) / Universitätsmedizin Mainz Mainz, DE	—	1 · Autogene cevumeran	3	0	5
153	University College London Hospitals / UCL Cancer Institute London, GB	—	—	5	0	5
154	University Hospital Southampton / Centre for Cancer Immunology Southampton, GB	—	—	4	1	5
155	University of Chicago Medicine Comprehensive Cancer Center Chicago, IL, US	—	—	3	2	5
156	Vanderbilt-Ingram Cancer Center Nashville, TN, US	—	1 · Osimertinib	1	2	5
157	Children's Cancer and Leukaemia Group Leicester, GB	1 · Euro Ewing 2012	—	1	0	4
158	A.C. Camargo Cancer Center São Paulo, BR	—	—	3	1	4
159	Aarhus University Hospital Aarhus, DK	—	—	4	0	4
160	Butaro Cancer Center of Excellence Butaro, RW	—	—	4	0	4
161	Cancer Hospital, Chinese Academy of Medical Sciences Beijing, CN	—	2 · Disitamab vedotin, Sacituzumab tirumotecan	0	0	4
162	Cancer Institute (WIA), Adyar Chennai, IN	—	—	4	0	4
163	Cancer Research UK Manchester Institute Manchester, GB	—	—	4	0	4
164	Champalimaud Foundation – Champalimaud Clinical Centre Lisbon, PT	—	—	4	0	4
165	Charlotte Maxeke Johannesburg Academic Hospital / University of the Witwatersrand Johannesburg, ZA	—	—	4	0	4
166	Children's Cancer Hospital Egypt 57357 Cairo, EG	—	—	4	0	4
167	Chris O'Brien Lifehouse Sydney, AU	—	—	4	0	4
168	Christian Medical College, Vellore Vellore, IN	—	—	4	0	4
169	Cleveland Clinic Abu Dhabi Abu Dhabi, AE	—	—	4	0	4
170	Comprehensive Cancer Center Freiburg (CCCF) Freiburg im Breisgau, DE	—	—	4	0	4
171	Dharmais National Cancer Center Jakarta, ID	—	—	4	0	4
172	Duke Cancer Institute Durham, NC, US	—	1 · Trastuzumab emtansine	1	1	4
173	EMBL's European Bioinformatics Institute Hinxton, GB	—	—	4	0	4
174	European Society of Gynaecological Oncology Prague, CZ	—	—	4	0	4
175	European Society of Surgical Oncology Brussels, BE	—	—	4	0	4
176	Frederick National Laboratory for Cancer Research Frederick, MD, US	—	—	3	1	4
177	Fundación Arturo López Pérez Santiago, CL	—	—	4	0	4
178	Garvan Institute of Medical Research / Kinghorn Cancer Centre Sydney, AU	—	—	4	0	4
179	Ghent University Hospital / Cancer Research Institute Ghent Ghent, BE	—	—	3	1	4
180	Great Ormond Street Hospital for Children London, GB	—	—	3	1	4
181	Groote Schuur Hospital / University of Cape Town Cape Town, ZA	—	—	4	0	4
182	HealthCare Global Enterprises Bengaluru, IN	—	—	4	0	4
183	Ho Chi Minh City Oncology Hospital Ho Chi Minh City, VN	—	—	4	0	4
184	Hospital Universitari i Politècnic La Fe Valencia, ES	—	—	4	0	4
185	HUS Comprehensive Cancer Center, Helsinki University Hospital Helsinki, FI	—	—	4	0	4
186	Institut National d'Oncologie, Rabat Rabat, MA	—	—	4	0	4
187	Institut Salah Azaïez Tunis, TN	—	—	4	0	4
188	Instituto Nacional de Câncer (INCA) Rio de Janeiro, BR	—	—	4	0	4
189	Instituto Nacional de Cancerología (Colombia) Bogotá, CO	—	—	4	0	4
190	Instituto Nacional de Enfermedades Neoplásicas Lima, PE	—	—	4	0	4
191	International Atomic Energy Agency – Rays of Hope Vienna, AT	—	—	4	0	4
192	Johns Hopkins Hospital / Sidney Kimmel Comprehensive Cancer Center Baltimore, US	—	1 · Pembrolizumab	2	0	4
193	Keio University Hospital Tokyo, JP	—	—	4	0	4
194	Koo Foundation Sun Yat-Sen Cancer Center Taipei, TW	—	—	4	0	4
195	Korle Bu Teaching Hospital Accra, GH	—	—	4	0	4
196	Leiden University Medical Center Leiden, NL	—	—	4	0	4
197	Maria Skłodowska-Curie National Research Institute of Oncology Warsaw, PL	—	—	4	0	4
198	Max Delbrück Center for Molecular Medicine Berlin, DE	—	—	4	0	4
199	Mayo Clinic Rochester, MN, US	—	—	4	0	4
200	Mays Cancer Center at UT Health San Antonio San Antonio, TX, US	—	2 · Gemcitabine, Ruxolitinib	0	0	4
201	Multinational Association of Supportive Care in Cancer Aurora, ON, CA	—	—	4	0	4
202	National Cancer Center Korea Goyang, KR	—	—	4	0	4
203	National Cancer Institute, Cairo University Cairo, EG	—	—	4	0	4
204	National University Hospital / National University Cancer Institute, Singapore Singapore, SG	—	—	4	0	4
205	Ocean Road Cancer Institute Dar es Salaam, TZ	—	—	4	0	4
206	Olivia Newton-John Cancer Wellness and Research Centre Melbourne, AU	—	—	4	0	4
207	QIMR Berghofer Medical Research Institute Brisbane, AU	—	—	3	1	4
208	Rajiv Gandhi Cancer Institute and Research Centre New Delhi, IN	—	—	4	0	4
209	Rigshospitalet – Copenhagen University Hospital Copenhagen, DK	—	—	4	0	4
210	Rosalind and Morris Goodman Cancer Institute, McGill University Montréal, QC, CA	—	—	2	2	4
211	Sahlgrenska University Hospital / Sahlgrenska Center for Cancer Research Gothenburg, SE	—	—	4	0	4
212	Shizuoka Cancer Center Nagaizumi, Shizuoka, JP	—	—	4	0	4
213	Skåne University Hospital / Lund University Cancer Centre Lund, SE	—	—	4	0	4
214	Tianjin Medical University Cancer Institute and Hospital Tianjin, CN	—	—	4	0	4
215	Tohoku University Hospital Sendai, JP	—	—	3	1	4
216	Tongji Hospital, Huazhong University of Science and Technology Wuhan, CN	—	—	4	0	4
217	Uganda Cancer Institute Kampala, UG	—	—	4	0	4
218	University Hospital Basel / Tumour Centre Basel, CH	—	—	4	0	4
219	University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center Baltimore, MD, US	—	—	4	0	4
220	USC Norris Comprehensive Cancer Center Los Angeles, CA, US	—	1 · Azacitidine	2	0	4
221	UVA Comprehensive Cancer Center Charlottesville, VA, US	—	—	4	0	4
222	Velindre Cancer Centre Cardiff, GB	—	—	4	0	4
223	Vietnam National Cancer Hospital (K Hospital) Hanoi, VN	—	—	4	0	4
224	West Japan Oncology Group Osaka, JP	—	1 · Osimertinib	2	0	4
225	Yale University Open Data Access (YODA) Project New Haven, CT, US	—	2 · Ciltacabtagene autoleucel, Teclistamab	0	0	4
226	Zhejiang Cancer Hospital Hangzhou, CN	—	—	4	0	4
227	Canadian Cancer Society Toronto, CA	1 · CHALLENGE	—	0	0	3
228	Karolinska University Hospital Stockholm, SE	1 · ALASCCA	—	0	0	3
229	Princess Margaret Cancer Centre Toronto, CA	1 · CHALLENGE	—	0	0	3
230	Advanced Research Projects Agency for Health Washington, DC, US	—	—	3	0	3
231	Aichi Cancer Center Nagoya, JP	—	—	1	2	3
232	American Society of Hematology Washington, DC, US	—	—	3	0	3
233	Apollo Hospitals (Apollo Cancer Centres) Chennai, IN	—	—	3	0	3
234	Atrium Health Wake Forest Baptist Comprehensive Cancer Center Winston-Salem, NC, US	—	—	3	0	3
235	Barts Cancer Institute / Barts Health NHS Trust London, GB	—	—	3	0	3
236	Breast Cancer Research Foundation New York, US	—	—	3	0	3
237	Broad Institute of MIT and Harvard Cambridge, MA, US	—	—	3	0	3
238	Cancer Care Alberta (Alberta Health Services) Calgary, AB, CA	—	—	3	0	3
239	Case Comprehensive Cancer Center Cleveland, OH, US	—	—	3	0	3
240	Centre Antoine Lacassagne Nice, FR	—	—	3	0	3
241	Centre Léon Bérard Lyon, FR	—	—	3	0	3
242	Centre Oscar Lambret Lille, FR	—	—	3	0	3
243	Chan Zuckerberg Biohub San Francisco, US	—	—	3	0	3
244	Chang Gung Memorial Hospital Taoyuan, TW	—	—	3	0	3
245	Edinburgh Cancer Centre / CRUK Scotland Centre Edinburgh, GB	—	—	3	0	3
246	European Hematology Association The Hague, NL	—	—	3	0	3
247	Geneva University Hospitals (HUG) Geneva, CH	—	—	3	0	3
248	Hacettepe University Cancer Institute Ankara, TR	—	—	3	0	3
249	Hamad Medical Corporation / National Center for Cancer Care and Research Doha, QA	—	—	3	0	3
250	Hokkaido University Hospital Sapporo, JP	—	—	3	0	3
251	Hospital de Amor (Barretos Cancer Hospital) Barretos, BR	—	—	3	0	3
252	Hospital de Clínicas de Porto Alegre Porto Alegre, BR	—	—	1	2	3
253	Hunan Cancer Hospital Changsha, CN	—	—	3	0	3
254	INCLIVA Biomedical Research Institute / Hospital Clínico Universitario de Valencia Valencia, ES	—	—	3	0	3
255	Institut Bergonié Bordeaux, FR	—	—	3	0	3
256	Institut Paoli-Calmettes Marseille, FR	—	—	3	0	3
257	Institut Pasteur Paris, FR	—	—	3	0	3
258	Instituto Português de Oncologia de Lisboa Francisco Gentil Lisbon, PT	—	—	3	0	3
259	Intergroupe Francophone de Cancérologie Thoracique Paris, FR	—	—	3	0	3
260	International Extranodal Lymphoma Study Group Bellinzona, CH	—	—	3	0	3
261	Istanbul University Institute of Oncology Istanbul, TR	—	—	3	0	3
262	Juravinski Cancer Centre / Escarpment Cancer Research Institute Hamilton, ON, CA	—	—	3	0	3
263	Kaiser Permanente Division of Research Oakland, CA, US	—	—	3	0	3
264	Kyushu University Hospital Fukuoka, JP	—	—	2	1	3
265	Leeds Cancer Centre, St James's University Hospital Leeds, GB	—	—	3	0	3
266	Lustgarten Foundation Woodbury, NY, US	—	—	3	0	3
267	Markey Cancer Center, University of Kentucky Lexington, KY, US	—	—	3	0	3
268	Masonic Cancer Center, University of Minnesota Minneapolis, MN, US	—	—	3	0	3
269	Moffitt Cancer Center Tampa, FL, US	—	1 · Lifileucel	1	0	3
270	Movember Melbourne, AU	—	—	3	0	3
271	MUSC Hollings Cancer Center Charleston, SC, US	—	—	3	0	3
272	National Institute of Oncology, Hungary Budapest, HU	—	—	3	0	3
273	Nationwide Children's Hospital Columbus, OH, US	—	—	3	0	3
274	Osaka International Cancer Institute Osaka, JP	—	—	3	0	3
275	Peking Union Medical College Hospital Beijing, CN	—	—	3	0	3
276	Prince of Wales Hospital / Chinese University of Hong Kong Hong Kong, HK	—	—	3	0	3
277	Rambam Health Care Campus Haifa, IL	—	—	3	0	3
278	Rutgers Cancer Institute of New Jersey New Brunswick, NJ, US	—	—	3	0	3
279	Shaare Zedek Medical Center Jerusalem, IL	—	—	2	1	3
280	Sidney Kimmel Comprehensive Cancer Center at Jefferson Health Philadelphia, PA, US	—	—	2	1	3
281	Siriraj Hospital, Mahidol University Bangkok, TH	—	—	3	0	3
282	St. Jude Children's Research Hospital Memphis, TN, US	—	—	3	0	3
283	Taipei Veterans General Hospital Taipei, TW	—	—	3	0	3
284	Tata Medical Center, Kolkata Kolkata, IN	—	—	3	0	3
285	Tel Aviv Sourasky Medical Center Tel Aviv, IL	—	—	3	0	3
286	Texas Children's Cancer and Hematology Center Houston, TX, US	—	—	2	1	3
287	The Hospital for Sick Children (SickKids) Toronto, ON, CA	—	—	3	0	3
288	The Jackson Laboratory Cancer Center Bar Harbor, ME, US	—	—	3	0	3
289	The Wistar Institute Philadelphia, PA, US	—	—	2	1	3
290	University Cancer Center Frankfurt (UCT) Frankfurt am Main, DE	—	—	3	0	3
291	University Hospitals Birmingham / University of Birmingham Cancer Research Centre Birmingham, GB	—	—	3	0	3
292	University of Malaya Medical Centre Kuala Lumpur, MY	—	—	2	1	3
293	University of New Mexico Comprehensive Cancer Center Albuquerque, NM, US	—	—	3	0	3
294	Arc Institute Palo Alto, CA, US	—	—	2	0	2
295	Auckland City Hospital / Te Pūriri o Te Ora Cancer and Blood Service Auckland, NZ	—	—	2	0	2
296	Barbara Ann Karmanos Cancer Institute Detroit, MI, US	—	—	1	1	2
297	Canadian Cancer Trials Group (CCTG) Kingston, ON, CA	—	—	2	0	2
298	Cancer Center at Illinois Urbana, IL, US	—	—	2	0	2
299	Cancer Institute of Iran, Imam Khomeini Hospital Complex Tehran, IR	—	—	2	0	2
300	Cedars-Sinai Cancer Los Angeles, CA, US	—	—	2	0	2
301	Chao Family Comprehensive Cancer Center, UC Irvine Orange, CA, US	—	—	2	0	2
302	City of Hope Duarte, CA, US	—	—	2	0	2
303	City of Hope Orange County Irvine, CA, US	—	—	2	0	2
304	Cleveland Clinic Taussig Cancer Institute Cleveland, US	—	—	2	0	2
305	Cold Spring Harbor Laboratory Cold Spring Harbor, NY, US	—	—	2	0	2
306	European Society for Clinical Nutrition and Metabolism Luxembourg, LU	—	—	2	0	2
307	FDA Oncology Center of Excellence Silver Spring, MD, US	—	—	2	0	2
308	First Affiliated Hospital of Sun Yat-sen University Guangzhou, CN	—	—	2	0	2
309	Fox Chase Cancer Center Philadelphia, PA, US	—	—	1	1	2
310	Fred & Pamela Buffett Cancer Center Omaha, NE, US	—	—	2	0	2
311	Fudan University Shanghai Cancer Center Shanghai, CN	—	—	1	1	2
312	German Cancer Research Center (DKFZ) Heidelberg, DE	—	—	2	0	2
313	German Lymphoma Alliance Homburg, DE	—	—	2	0	2
314	Henan Cancer Hospital Zhengzhou, CN	—	—	2	0	2
315	Japanese Society of Medical Oncology Tokyo, JP	—	—	2	0	2
316	Kidwai Memorial Institute of Oncology Bengaluru, IN	—	—	2	0	2
317	Korean Cancer Study Group Seoul, KR	—	—	2	0	2
318	Mayo Clinic Comprehensive Cancer Center – Arizona Phoenix, AZ, US	—	—	2	0	2
319	Medicines and Healthcare products Regulatory Agency London, GB	—	—	2	0	2
320	Nordic Lymphoma Group Stockholm, SE	—	—	2	0	2
321	Ontario Institute for Cancer Research Toronto, ON, CA	—	—	2	0	2
322	Philippine General Hospital Manila, PH	—	—	2	0	2
323	QST Hospital (National Institutes for Quantum Science and Technology) Chiba, JP	—	—	2	0	2
324	Queen Mary Hospital / University of Hong Kong Hong Kong, HK	—	—	2	0	2
325	Ramathibodi Hospital, Mahidol University Bangkok, TH	—	—	2	0	2
326	Royal Adelaide Hospital Adelaide, AU	—	—	2	0	2
327	Salk Institute Cancer Center La Jolla, CA, US	—	—	2	0	2
328	Sanford Burnham Prebys Medical Discovery Institute La Jolla, CA, US	—	—	2	0	2
329	Severance Hospital, Yonsei University Seoul, KR	—	—	2	0	2
330	Siteman Cancer Center, Washington University St. Louis, MO, US	—	—	2	0	2
331	Sylvester Comprehensive Cancer Center, University of Miami Miami, FL, US	—	—	2	0	2
332	Tawam Hospital Al Ain, AE	—	—	2	0	2
333	The Francis Crick Institute London, GB	—	—	2	0	2
334	The Ottawa Hospital Cancer Centre / Ottawa Hospital Research Institute Ottawa, ON, CA	—	—	2	0	2
335	The University of Kansas Cancer Center Kansas City, KS, US	—	—	2	0	2
336	UNC Lineberger Comprehensive Cancer Center Chapel Hill, NC, US	—	—	2	0	2
337	University of Florida Health Cancer Center Gainesville, FL, US	—	—	2	0	2
338	Wellcome London, GB	—	—	2	0	2
339	Wilmot Cancer Institute, University of Rochester Rochester, NY, US	—	—	2	0	2
340	Asan Medical Center Seoul, KR	—	—	1	0	1
341	Charité – Universitätsmedizin Berlin Berlin, DE	—	—	1	0	1
342	European Cancer Organisation Brussels, BE	—	—	1	0	1
343	European Medicines Agency Amsterdam, NL	—	—	1	0	1
344	Fondazione IRCCS Istituto Nazionale dei Tumori Milan, IT	—	—	1	0	1
345	Fred Hutchinson Cancer Center Seattle, US	—	—	1	0	1
346	Gates Foundation Seattle, WA, US	—	—	1	0	1
347	Gunma University Heavy Ion Medical Center Maebashi, JP	—	—	1	0	1
348	HL7 International Ann Arbor, MI, US	—	—	1	0	1
349	Howard Hughes Medical Institute Chevy Chase, MD, US	—	—	1	0	1
350	IEO – European Institute of Oncology Milan, IT	—	—	1	0	1
351	Institut Curie Paris, FR	—	—	1	0	1
352	Institute for Protein Design (University of Washington) Seattle, US	—	—	1	0	1
353	Intermountain Health Cancer Center Salt Lake City, UT, US	—	—	1	0	1
354	LMU Klinikum München Munich, DE	—	—	1	0	1
355	Northwell Health Cancer Institute New Hyde Park, NY, US	—	—	1	0	1
356	O'Neal Comprehensive Cancer Center at UAB Birmingham, AL, US	—	—	1	0	1
357	Providence Health & Services Renton, WA, US	—	—	1	0	1
358	Roswell Park Comprehensive Cancer Center Buffalo, NY, US	—	—	1	0	1
359	The Christie NHS Foundation Trust Manchester, GB	—	—	1	0	1
360	Therapeutic Goods Administration Canberra, AU	—	—	1	0	1
361	UNICANCER Paris, FR	—	—	1	0	1
362	University of Arizona Cancer Center Tucson, AZ, US	—	—	1	0	1
363	University of Michigan Rogel Cancer Center Ann Arbor, MI, US	—	—	1	0	1
364	World Health Organization – Cancer Programme Geneva, CH	—	—	1	0	1
365	Yale School of Medicine / Yale Cancer Center New Haven, CT, US	—	—	1	0	1